Boston Scientific Corp. (BSX): Price and Financial Metrics

BSX POWR Grades

• Growth is the dimension where BSX ranks best; there it ranks ahead of 88.35% of US stocks.
• The strongest trend for BSX is in Quality, which has been heading up over the past 177 days.
• BSX ranks lowest in Value; there it ranks in the 36th percentile.

BSX Stock Summary

• BSX has a market capitalization of $69,185,096,615 -- more than approximately 96.98% of US stocks.
• With a one year PEG ratio of 791.21, BOSTON SCIENTIFIC CORP is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 96.38% of US stocks.
• BSX's current price/earnings ratio is 107.76, which is higher than 95.28% of US stocks with positive earnings.
• If you're looking for stocks that are quantitatively similar to BOSTON SCIENTIFIC CORP, a group of peers worth examining would be ZTS, ABB, UBER, MSCI, and ALC.
• BSX's SEC filings can be seen here. And to visit BOSTON SCIENTIFIC CORP's official web site, go to www.bostonscientific.com.

BSX Valuation Summary

• BSX's price/sales ratio is 5.5; this is 189.47% higher than that of the median Healthcare stock.
• Over the past 243 months, BSX's price/sales ratio has gone down 0.4.

Below are key valuation metrics over time for BSX.

BSX Growth Metrics

Its 5 year net income to common stockholders growth rate is now at 885.52%.
• Its year over year cash and equivalents growth rate is now at -83.88%.
• The year over year net income to common stockholders growth rate now stands at 275.12%.

Over the past 70 months, BSX's revenue has gone up $4.1e+09.

The table below shows BSX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	12,682	1,526	642
2022-09-30	12,567	1,197	597
2022-06-30	12,329	1,192	828
2022-03-31	12,162	1,528	754
2021-12-31	11,888	1,870	985
2021-09-30	11,470	2,065	1,100

BSX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• BSX has a Quality Grade of C, ranking ahead of 73.14% of graded US stocks.
• BSX's asset turnover comes in at 0.362 -- ranking 120th of 186 Medical Equipment stocks.
• INGN, ECIA, and ATRC are the stocks whose asset turnover ratios are most correlated with BSX.

The table below shows BSX's key quality metrics over time.